MARIO Study: IV Echinocandin Followed by Oral Ibrexafungerp or Oral Fluconazole
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
a study on Invasive Candidiasis Candidemia
- for people ages 18 years and up (full criteria)
- at Sacramento, California and other locations
- study startedestimated completion
Candidiasis, Invasive, Candidemia, Candidiasis, Invasive Candidiasis, Fluconazole, Caspofungin, Micafungin, Anidulafungin, Ibrexafungerp, Echinocandins, SCY-078, Echinocandin, IV echinocandin followed by oral ibrexafungerp (SCY-078), IV echinocandin followed by oral fluconazole
- accepting new patients
- Start Date
- Completion Date
- Scynexis, Inc.
- Sign up for this study
- Phase 3 research study
- Study Type
- Expecting 220 study participants
- Last Updated